Arrakis Therapeutics
Discovering a New World of Therapeutics

The therapeutic potential of the human transcriptome, the set of all RNAs transcribed from DNA, remains largely unexplored. By harnessing new insights into RNA structure and dynamics, Arrakis is opening the transcriptome to therapy by small-molecule medicines to treat patients not cured by today’s medicines. We aim to unlock the therapeutic potential of deeply researched, valuable targets and to identify new disease intervention points that may be uniquely addressed with RNA-targeted small molecules.

Back to Top